Cargando…
Dysbiosis modulates capacity for bile acid modification in the gut microbiomes of patients with inflammatory bowel disease: a mechanism and marker of disease?
Autores principales: | Ogilvie, Lesley A, Jones, Brian V |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Group
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3463861/ https://www.ncbi.nlm.nih.gov/pubmed/22490526 http://dx.doi.org/10.1136/gutjnl-2012-302137 |
Ejemplares similares
-
Role of the gut microbiome in mediating lactose intolerance symptoms
por: Brandao Gois, M F, et al.
Publicado: (2022) -
Serological responses to three doses of SARS-CoV-2 vaccination in inflammatory bowel disease
por: Quan, Joshua, et al.
Publicado: (2023) -
Role of endoscopy in chronic diarrhoea when functional bowel disease is suspected
por: Arasaradnam, Ramesh P, et al.
Publicado: (2020) -
First known case of paediatric inflammatory bowel disease in a western lowland gorilla may be linked to a familial mutation in the MEFV gene
por: Petersen, Britt-Sabina, et al.
Publicado: (2020) -
Ageing trajectory of the gut microbiota is associated with metabolic diseases in a chronological age-dependent manner
por: Fu, JingXiang, et al.
Publicado: (2023)